Patents by Inventor Beatrice Drexler

Beatrice Drexler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of GDF-15, natriuretic peptide, cardiac troponin or combinations thereof
    Patent number: 8951742
    Abstract: The present invention relates to a method of identifying a subject being susceptible to a cardiac intervention based on the determination of GDF-15 in a sample of a subject in need of a cardiac intervention. Moreover, the present invention pertains to a method for predicting the risk of mortality or a further acute cardiovascular event for a subject suffering from a cardiovascular complication based on the determination of GDF-15 and a natriuretic peptide and/or a cardiac troponin in a sample the said subject. Also encompassed by the present invention are devices and kits for carrying out the aforementioned methods.
    Type: Grant
    Filed: February 2, 2009
    Date of Patent: February 10, 2015
    Assignee: Medizinische Hochschule Hannover
    Inventors: Kai C. Wollert, Tibor Kempf, Lars Wallentin, Christa Marianne Drexler, Beatrice Drexler
  • ASSESSING RISK OF CARDIAC INTERVENTION BASED ON GDF-15
    Publication number: 20110065204
    Abstract: The present invention relates to a method of identifying a subject being susceptible to a cardiac intervention based on the determination of GDF-15 in a sample of a subject in need of a cardiac intervention. Moreover, the present invention pertains to a method for predicting the risk of mortality or a further acute cardiovascular event for a subject suffering from a cardiovascular complication based on the determination of GDF-15 and a natriuretic peptide and/or a cardiac troponin in a sample the said subject. Also encompassed by the present invention are devices and kits for carrying out the aforementioned methods.
    Type: Application
    Filed: February 2, 2009
    Publication date: March 17, 2011
    Inventors: Kai C. Wollert, Tibor Kempf, Lars Wallentin, Helmut Drexler, Christa Marianne Drexler, Beatrice Drexler